Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-06-14
2005-06-14
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S326000, C514S331000, C544S129000, C546S209000, C546S210000, C546S231000
Reexamination Certificate
active
06906066
ABSTRACT:
The present application describes modulators of CCR3 of formula (I):or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
REFERENCES:
patent: 2993897 (1961-07-01), Shapiro et al.
patent: 3988294 (1976-10-01), Hill
patent: 5001134 (1991-03-01), Ferrand et al.
patent: 5236921 (1993-08-01), Emonds-Ai et al.
patent: 5317020 (1994-05-01), Emonds-Alt et al.
patent: 6331541 (2001-12-01), Ko et al.
patent: 6444686 (2002-09-01), Ko et al.
patent: 6525069 (2003-02-01), Ko et al.
patent: 2614189 (1977-10-01), None
patent: 0293880 (1988-12-01), None
patent: 90/15048 (1990-12-01), None
patent: 94/27992 (1994-12-01), None
patent: 0685463 (1995-12-01), None
patent: 903349 (1999-03-01), None
patent: 479601 (1999-12-01), None
patent: 747357 (2002-01-01), None
patent: 1261383 (1989-10-01), None
patent: WO 94/27991 (1994-12-01), None
patent: WO 95/07266 (1995-03-01), None
patent: WO 96/24587 (1996-08-01), None
patent: WO 97/03060 (1997-01-01), None
patent: WO 97/19060 (1997-05-01), None
patent: WO 97/24325 (1997-07-01), None
patent: WO 97/40007 (1997-10-01), None
patent: WO 01/98270 (1999-05-01), None
patent: WO 99/24442 (1999-05-01), None
patent: WO 99/40931 (1999-08-01), None
patent: WO 00/29377 (2000-05-01), None
Kemp, et al., “Latent Inhibitors—Part 9”,J. Chem. Soc., Perkin Trans2 , 1993, vol. 4, pp. 741-748.
Ner et al., J. Of Chem. Soc.,Chem Commun, 1987, vol. 6, pp. 480-482.
Kim, et al., “Migration and proliferation of guinea pig and human airway epithelial cells in response to tachkykinins”,Am. J. Physiol., 1995, vol. 269, pp. L119-L126,Chem. Abstract No. 123:133809.
Kraneveld, et al., “Airway hyperresponsiveness; first eosinophils and then neuropeptides”,Int. J.Immunopharmacoo., 1998, vol. 19, 9/10, pp. 517-527,Chem Abstract No. 129:107602.
Delucca George V.
Duncia John V.
Ko Soo S.
Santella III Joseph B.
Varnes Jeffrey G.
Bristol-Myers Squibb Pharma Company
Rao Deepak
VanAtten Mary
LandOfFree
N-ureidoalkyl-piperidines as modulators of chemokine... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-ureidoalkyl-piperidines as modulators of chemokine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-ureidoalkyl-piperidines as modulators of chemokine... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3498950